PEAR THERAPEUTICS INC (PEAR)

US7047231052 - Common Stock

0.0292  -0.02 (-38.91%)

After market: 0.0287 0 (-1.71%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

PEAR THERAPEUTICS INC

NASDAQ:PEAR (4/18/2023, 7:27:07 PM)

After market: 0.0287 0 (-1.71%)

0.0292

-0.02 (-38.91%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.17M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PEAR Daily chart

Company Profile

Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The company is headquartered in Boston, Massachusetts and currently employs 200 full-time employees. The company went IPO on 2021-02-02. The firm is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases. Its products include reset, reSET-O and Somryst. The firm's reset product is indicated for the treatment of substance use disorder (SUD) related to alcohol, cannabis, cocaine and stimulants, such as monotherapy. Its reSET-O product is developed for the treatment of opioid use disorder (OUD) in combination with buprenorphine. The firm's Somryst product is the only software-based and guideline-recommended treatment for chronic insomnia. The Company’s pipeline consists of 14 product candidates, including candidates in psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal (GI), oncology, and cardiovascular. The firm focuses on psychiatric and neurologic conditions.

Company Info

PEAR THERAPEUTICS INC

200 State Street, 13Th Floor

Boston MASSACHUSETTS

P: 16469322774.0

Employees: 200

Website: https://peartherapeutics.com/

PEAR News

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

News Imagea year ago - InvestorPlaceWhy Is Mind Medicine (MNMD) Stock Up 26% Today?

Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).

News Imagea year ago - InvestorPlaceWhy Is National CineMedia (NCMI) Stock Down 12% Today?

National CineMedia (NCMI) stock is on the move Friday as the movie theater ad company's shares continue to see wild swings this week.

News Imagea year ago - InvestorPlaceWhy Is Pear Therapeutics (PEAR) Stock Down 26% Today?

Pear Therapeutics (PEAR) stock is falling on Friday after the company's recent bankruptcy filing continues to weigh on its shares.

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time for another dive into the biggest pre-market stock movers with all the latest news traders need to know about for Friday!

News Imagea year ago - InvestorPlace7 Tech Stocks to Avoid Like the Plague in April

Not all tech stocks are alike. Some are doing very nicely and have a great future ahead this spring, but there are plenty of others to avoid.

PEAR Twits

Here you can normally see the latest stock twits on PEAR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example